KRKA Repaglinide tablets

Repaglinide is a pharmaceutical product manufactured by KRKA, a leading international generic pharmaceutical company. It is primarily used as an oral antidiabetic medication to help control blood sugar levels in people with type 2 diabetes. The brand KRKA is deeply rooted in Central Europe, maintaining high standards of production within the European Union.

The product is manufactured in the KRKA production facilities, predominantly located in Slovenia. As a vertically integrated company, KRKA manages the development, production, and distribution of its pharmaceutical products, ensuring consistent quality throughout the supply chain. The company remains an independent entity with its own production sites and research laboratories, focusing on accessible high-quality generic medicines.